mobile btn
Monday, June 14th, 2021

Emerging Infectious Diseases

CARB-X funds earmarked for antibiotics research

Basel, Switzerland-based pharmaceutical company BioVersys has secured a $4.35 million funding allotment from CARB-X to develop new antibiotics to treat life-threatening infections caused by ESKAPE pathogens. The pathogens are identified as bacteria that have developed resistance to most current,... Read More »

DOD funds earmarked for nitrile gloves production

Renco Corporation has secured a $13.1 million contract via the Department of Defense (DOD) and the Department of Health and Human Services (HHS) to bolster domestic nitrile gloves production. Under the agreement, the initiative enables Renco to increase the production capacity of nitrile gloves... Read More »